Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Femasys (FEMY) Long-Term Debt Issuances (2020 - 2025)

Femasys posted quarterly Long-Term Debt Issuances of $100001.0 for Q2 2025, down 82.09% on a QoQ basis from $558367.0 in Q2 2021.

Femasys (FEMY) has 3 years of Long-Term Debt Issuances data on file, last reported at $100001.0 in Q2 2025.

  • For the quarter ending Q2 2025, Long-Term Debt Issuances changed N/A year-over-year to $100001.0; the trailing twelve-month figure through Jun 2025 stood at $658368.0 (changed N/A YoY), and the FY2025 full-year result was $12.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q2 2025 stood at $100001.0, down from $558367.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $558367.0 in Q2 2021 and bottomed at $64842.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 46.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 875.40 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 5.04 Mn
10 Femasys 22.30 Mn 16.91 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 100,001.00
Jun 30, 2025 100,001.00
Jun 30, 2021 558,367.00
Jun 30, 2021 558,367.00
Mar 31, 2021 64,842.00
Mar 31, 2021 64,842.00
Dec 31, 2020 -10,000.00
Dec 31, 2020 -10,000.00